ZIM Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
ZIM Laboratories has a total shareholder equity of ₹2.4B and total debt of ₹1.1B, which brings its debt-to-equity ratio to 44.5%. Its total assets and total liabilities are ₹4.5B and ₹2.1B respectively. ZIM Laboratories's EBIT is ₹256.7M making its interest coverage ratio 4.5. It has cash and short-term investments of ₹98.8M.
Key information
44.5%
Debt to equity ratio
₹1.06b
Debt
Interest coverage ratio | 4.5x |
Cash | ₹98.84m |
Equity | ₹2.39b |
Total liabilities | ₹2.08b |
Total assets | ₹4.47b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 541400's short term assets (₹2.3B) exceed its short term liabilities (₹1.6B).
Long Term Liabilities: 541400's short term assets (₹2.3B) exceed its long term liabilities (₹486.5M).
Debt to Equity History and Analysis
Debt Level: 541400's net debt to equity ratio (40.4%) is considered high.
Reducing Debt: 541400's debt to equity ratio has reduced from 51.3% to 44.5% over the past 5 years.
Debt Coverage: 541400's debt is not well covered by operating cash flow (15.3%).
Interest Coverage: 541400's interest payments on its debt are well covered by EBIT (4.5x coverage).